Vicks Inhaler

Valsts: Malta

Valoda: angļu

Klimata pārmaiņas: Malta Medicines Authority

Aktīvā sastāvdaļa:

CAMPHOR, PINE OIL, MENTHOL

Pieejams no:

Procter & Gamble (Health & Beauty Care) Limited

ATĶ kods:

R01AX30

SNN (starptautisko nepatentēto nosaukumu):

CAMPHOR, PINE OIL, MENTHOL

Zāļu forma:

NASAL STICK

Kompozīcija:

CAMPHOR 50 milligram(s) ; PINE OIL 10 milligram(s) ; MENTHOL 125 milligram(s)

Receptes veids:

OTC

Ārstniecības joma:

NASAL PREPARATIONS

Autorizācija statuss:

Authorised

Autorizācija datums:

2007-03-02

Lietošanas instrukcija

INHALER NASAL STICK
_MENTHOL 125MG CAMPHOR 50MG_
_SIBERIAN PINE NEEDLE OIL 10MG_
_FAST RELIEF FROM STUFFY NOSES_
INHALER NASAL STICK
_MENTHOL 125MG CAMPHOR 50MG_
_SIBERIAN PINE NEEDLE OIL 10MG_
_FAST RELIEF FROM STUFFY NOSES_
Vicks Inhaler is a Nasal stick (0.5ml 
medication) for nasal use. Insert well into nostril.
Inhale deeply to make breathing feel cool and clear. 
NOT RECOMMENDED FOR CHILDREN
UNDER 6 YEARS.
ACTIVE INGREDIENTS: Menthol
125mg, Camphor 50mg, Siberian
Pine Needle Oil 10mg. 
Do not store above 25˚C.
KEEP OUT OF SIGHT AND REACH 
OF CHILDREN.
For Expiry & Lot No. see base.
PL 0129/5009R   PA 441/27/1
Relief of nasal congestion associated with:
•  Upper respiratory tract disorders
•  Allergies
DIRECTIONS FOR USE:_ _(adults & children 6 years 
& over): Use as often as needed. Remove the 
screw cap. Insert  well into nostril, holding 
the other nostril closed. Inhale deeply to 
make breathing feel clear and cool.
NOT RECOMMENDED FOR CHILDREN UNDER 6 YEARS:   
Do not store above 25°C.
_ _
DO NOT USE VICKS INHALER:
•  if you are allergic to any of its  
ingredients
•  after the expiry date
NOT RECOMMENDED FOR CHILDREN
UNDER 6 YEARS.

If your symptoms persist or worsen 
consult your doctor or pharmacist. 
Nasal discomfort may occur very 
rarely.

Do not store above 25°C
KEEP OUT OF THE SIGHT AND REACH 
OF CHILDREN
FURTHER INFORMATION
All enquiries to licence holder: 
Procter & Gamble (Health & Beauty Care) 
Limited, The Heights, Brooklands, 
Weybridge, Surrey, 
KT13 0XP, UK
Manufactured by: Procter & Gamble, 
Manufacturing GmbH Procter & Gamble 
Strasse 1, 64521 Gross-Gerau, Germany
For expiry date and lot no. see base

Text prepared 10/2010
PL 0129/5009R   PA 441/27/1
WHAT IS VICKS INHALER AND HOW
DOES IT WORK?
_ _
Vicks Inhaler is a nasal decongestant stick 
(0.5 ml medication) it contains the active 
ingredients:   
 • Menthol (125mg)
 • Camphor (50mg) 

 • Siberian Pine Needle Oil (10mg)      
It also contains methyl

Produkta apraksts

Page 1 of 3 
SUMMARY OF PRODUCT CHARACTERISTICS 

1. 
NAME OF THE PROPRIETARY MEDICINAL PRODUCT 

Vicks Inhaler 

2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 

ACTIVE INGREDIENTS 

mg/inhaler 

Specification 

Menthol 
125.00 
EP 

Camphor 
50.00 
EP 

Siberian Pine Needle Oil 
10.00 
FP 

3. 
PHARMACEUTICAL FORM (INCLUDING ROUTE OF ADMINISTRATION) 

Nasal stick; for nasal use. 

4. 
CLINICAL PARTICULARS 

4.1 
THERAPEUTIC INDICATIONS 

The relief of nasal congestion associated with allergic and infectious upper respiratory tract 

disorders. 

4.2 
POSOLOGY AND METHOD OF ADMINISTRATION 

Adults and children over 6 years: 
Vicks Inhaler is used by inserting the inhaler into each  
nostril, holding the other nostril closed and inhaling deeply. 

It can be used as frequently as needed. 

Children under 6 years:   
Not recommended. 

4.3 
CONTRAINDICATIONS 

Use in patients hypersensitive to any of the ingredients. 

4.4 
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE 

If symptoms persist consult your doctor. 

4.5 
INTERACTION WITH OTHER MEDICAMENTS AND OTHER FORMS OF 
INTERACTION 

None known. 

Page 2 of 3 
4.6 
USE DURING PREGNANCY AND LACTATION 

There is no evidence to indicate that this product should not be used during pregnancy and lactation. 

4.7 
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES 

None. 

4.8 
UNDESIRABLE EFFECTS 

 In general no serious or severe side effects are expected with this product. 
Very rarely cases of nasal discomfort have been reported. 

4.9 
OVERDOSE 

4.9.1 
SYMPTOMS 

No clinically significant cases of overdose have been reported. 

4.9.2 
TREATMENT OF OVERDOSE 

None.